RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Qing Li to Prostatic Neoplasms

This is a "connection" page, showing publications Qing Li has written about Prostatic Neoplasms.
Connection Strength

0.438
  1. Li QQ, Wang G, Reed E, Huang L, Cuff CF. Evaluation of cisplatin in combination with ?-elemene as a regimen for prostate cancer chemotherapy. Basic Clin Pharmacol Toxicol. 2010 Nov; 107(5):868-76.
    View in: PubMed
    Score: 0.196
  2. Li QQ, Wang G, Huang F, Banda M, Reed E. Antineoplastic effect of beta-elemene on prostate cancer cells and other types of solid tumour cells. J Pharm Pharmacol. 2010 Aug; 62(8):1018-27.
    View in: PubMed
    Score: 0.193
  3. Mo L, Zhang J, Shi J, Xuan Q, Yang X, Qin M, Lee C, Klocker H, Li QQ, Mo Z. Human kallikrein 7 induces epithelial-mesenchymal transition-like changes in prostate carcinoma cells: a role in prostate cancer invasion and progression. Anticancer Res. 2010 Sep; 30(9):3413-20.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support